Publication | Closed Access

Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome

ObesityMetabolic SyndromeInsulin ResistanceStatin Group DrugMetabolic DisorderMedicineDiabetesEndocrinologyPharmacologyInsulin SignalingHealth Sciences